Psyence Biomedical (PBM) Research & Development (2023 - 2025)
Psyence Biomedical's (PBM) quarterly Research & Development came in at $357444.0 in Q3 2025, up 34.57% year-on-year from $265626.0 in Q3 2024, and up 34.57% quarter-over-quarter from $265626.0 in Q3 2024.
Psyence Biomedical (PBM) Research & Development (2023 - 2025) Analysis & Trends
Psyence Biomedical's Research & Development history runs 3 years deep, the most recent figure standing at $357444.0 for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Psyence Biomedical | 1.56 Mn | 1.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 357,444.00 |
| Sep 30, 2024 | 265,626.00 |
| Sep 30, 2023 | -8,539.00 |